Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells
- 30 September 2007
- journal article
- Published by Elsevier BV in Pharmacological Research
- Vol. 56 (3), 193-201
- https://doi.org/10.1016/j.phrs.2007.06.003
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarineCell Biology and Toxicology, 2006
- Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cellsChemico-Biological Interactions, 2005
- Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by berberine through nuclear factor-κB signaling pathway in HepG2 cellsJournal of Biomedical Science, 2005
- Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditionsInnate Immunity, 2003
- Gastrointestinal side effects of drugsExpert Opinion on Drug Safety, 2003
- Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophagesLife Sciences, 2003
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitisEuropean Respiratory Journal, 1994
- Chelerythrine is a potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1990
- A REVIEW ON THE CHEMICAL AND PHARMACOLOGICAL ASPECTS OF GENUSBERBERISPlanta Medica, 1975